PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsCmab819
Cmab819
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
121 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MelanomaD008545——1281——19
Renal cell carcinomaD002292EFO_0000376—882——17
CarcinomaD002277—C80.0474——13
NeoplasmsD009369—C80761——13
Lung neoplasmsD008175—C34.90661—113
Non-small-cell lung carcinomaD002289——552—112
LymphomaD008223—C85.9353——11
AdenocarcinomaD000230——462——10
Squamous cell carcinomaD002294——273——10
Hodgkin diseaseD006689—C81532——9
Show 23 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-hodgkin lymphomaD008228—C85.965———10
Neoplasm metastasisD009362EFO_0009708—92———10
Breast neoplasmsD001943EFO_0003869C5062———8
Ovarian neoplasmsD010051EFO_0003893C5644———8
RecurrenceD012008——15———6
B-cell chronic lymphocytic leukemiaD015451—C91.133———6
Ovarian epithelial carcinomaD000077216——33———6
Hematologic neoplasmsD019337——41———5
Prostatic neoplasmsD011471—C6123———5
Multiple myelomaD009101—C90.023———5
Show 132 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Castration-resistant prostatic neoplasmsD064129——2————2
Myeloproliferative disordersD009196—D47.12————2
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_0000340—2————2
Myeloid leukemiaD007951—C922————2
SyndromeD013577——2————2
Kaposi sarcomaD012514—C462————2
Central nervous system neoplasmsD016543——2————2
Uveal neoplasmsD014604EFO_1001230—2————2
Uveal melanomaD000098943——2————2
Primary myelofibrosisD055728—D47.41————1
Show 37 more
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use